These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

346 related items for PubMed ID: 7594444

  • 1. Neutral endopeptidase versus angiotensin converting enzyme inhibition in essential hypertension.
    Favrat B, Burnier M, Nussberger J, Lecomte JM, Brouard R, Waeber B, Brunner HR.
    J Hypertens; 1995 Jul; 13(7):797-804. PubMed ID: 7594444
    [Abstract] [Full Text] [Related]

  • 2. A randomized, double-blind, placebo-controlled, parallel-group study to assess the efficacy and safety of dual ACE/NEP inhibitor GW660511X in mild-to-moderate hypertensive patients.
    Johnson AG, Pearce GL, Danoff TM.
    J Hum Hypertens; 2006 Jul; 20(7):496-503. PubMed ID: 16543907
    [Abstract] [Full Text] [Related]

  • 3. Combined inhibition of neutral endopeptidase and angiotensin-converting enzyme by sampatrilat in essential hypertension.
    Wallis EJ, Ramsay LE, Hettiarachchi J.
    Clin Pharmacol Ther; 1998 Oct; 64(4):439-49. PubMed ID: 9797801
    [Abstract] [Full Text] [Related]

  • 4. Candoxatril, a neutral endopeptidase inhibitor: efficacy and tolerability in essential hypertension.
    Bevan EG, Connell JM, Doyle J, Carmichael HA, Davies DL, Lorimer AR, McInnes GT.
    J Hypertens; 1992 Jul; 10(7):607-13. PubMed ID: 1321186
    [Abstract] [Full Text] [Related]

  • 5. Acute inhibition of endopeptidase 24.11 in essential hypertension: SCH 34826 enhances atrial natriuretic peptide and natriuresis without lowering blood pressure.
    Richards AM, Crozier IG, Espiner EA, Ikram H, Yandle TG, Kosoglou T, Rallings M, Frampton C.
    J Cardiovasc Pharmacol; 1992 Jul; 20(5):735-41. PubMed ID: 1280735
    [Abstract] [Full Text] [Related]

  • 6. Renal and vascular effects of S21402, a dual inhibitor of angiotensin-converting enzyme and neutral endopeptidase, in healthy subjects with hypovolemia.
    Chodjania Y, Tharaux PL, Ragueneau I, Dussaule JC, Picker JL, Funck-Brentano C, Jaillon P.
    Clin Pharmacol Ther; 2002 Jun; 71(6):468-78. PubMed ID: 12087350
    [Abstract] [Full Text] [Related]

  • 7. [Effect of sinorphan, an endopeptidase inhibitor on severe congestive cardiac insufficiency].
    Varin J, Duboc D, Weber S, Fouchard J, Schwartz JC, Muffat-Joly M, Guérin F.
    Arch Mal Coeur Vaiss; 1991 Oct; 84(10):1465-71. PubMed ID: 1662033
    [Abstract] [Full Text] [Related]

  • 8. An 18-week, prospective, randomized, double-blind, multicenter study of amlodipine/ramipril combination versus amlodipine monotherapy in the treatment of hypertension: the assessment of combination therapy of amlodipine/ramipril (ATAR) study.
    Miranda RD, Mion D, Rocha JC, Kohlmann O, Gomes MA, Saraiva JF, Amodeo C, Filho BL.
    Clin Ther; 2008 Sep; 30(9):1618-28. PubMed ID: 18840367
    [Abstract] [Full Text] [Related]

  • 9. Effects of converting enzyme inhibitor and neutral endopeptidase inhibitor on blood pressure and renal function in experimental hypertension.
    Pham I, Gonzalez W, el Amrani AI, Fournié-Zaluski MC, Philippe M, Laboulandine I, Roques BP, Michel JB.
    J Pharmacol Exp Ther; 1993 Jun; 265(3):1339-47. PubMed ID: 8389863
    [Abstract] [Full Text] [Related]

  • 10. Neutral endopeptidase inhibition augments vascular actions of bradykinin in patients treated with angiotensin-converting enzyme inhibition.
    Cruden NL, Fox KA, Ludlam CA, Johnston NR, Newby DE.
    Hypertension; 2004 Dec; 44(6):913-8. PubMed ID: 15492133
    [Abstract] [Full Text] [Related]

  • 11. Olive (Olea europaea) leaf extract effective in patients with stage-1 hypertension: comparison with Captopril.
    Susalit E, Agus N, Effendi I, Tjandrawinata RR, Nofiarny D, Perrinjaquet-Moccetti T, Verbruggen M.
    Phytomedicine; 2011 Feb 15; 18(4):251-8. PubMed ID: 21036583
    [Abstract] [Full Text] [Related]

  • 12. Determinants of in vivo activity of neutral endopeptidase 3.4.24.11 and angiotensin converting enzyme inhibitors.
    Seymour AA, Asaad MM, Abboa-Offei BE, Smith PL, Rogers WL, Dorso CR.
    J Pharmacol Exp Ther; 1996 Feb 15; 276(2):708-13. PubMed ID: 8632340
    [Abstract] [Full Text] [Related]

  • 13. Efficacy and safety of delapril plus manidipine compared with enalapril plus hydrochlorothiazide in mild to moderate essential hypertension: results of a randomized trial.
    Mugellini A, Dobovisek J, Planinc D, Cremonesi G, Fogari R.
    Clin Ther; 2004 Sep 15; 26(9):1419-26. PubMed ID: 15531004
    [Abstract] [Full Text] [Related]

  • 14. Sibutramine is safe and effective for weight loss in obese patients whose hypertension is well controlled with angiotensin-converting enzyme inhibitors.
    McMahon FG, Weinstein SP, Rowe E, Ernst KR, Johnson F, Fujioka K, Sibutramine in Hypertensives Clinical Study Group.
    J Hum Hypertens; 2002 Jan 15; 16(1):5-11. PubMed ID: 11840224
    [Abstract] [Full Text] [Related]

  • 15. A 16-week, randomized, double-blind, placebo-controlled, crossover trial to quantify the combined effect of an angiotensin-converting enzyme inhibitor and a beta-blocker on blood pressure reduction.
    Wald DS, Law M, Mills S, Bestwick JP, Morris JK, Wald NJ.
    Clin Ther; 2008 Nov 15; 30(11):2030-9. PubMed ID: 19108791
    [Abstract] [Full Text] [Related]

  • 16. Systemic hemodynamics, renal function and hormonal levels during inhibition of neutral endopeptidase 3.4.24.11 and angiotensin-converting enzyme in conscious dogs with pacing-induced heart failure.
    Seymour AA, Asaad MM, Lanoce VM, Langenbacher KM, Fennell SA, Rogers WL.
    J Pharmacol Exp Ther; 1993 Aug 15; 266(2):872-83. PubMed ID: 8394922
    [Abstract] [Full Text] [Related]

  • 17. Comparison of the antihypertensive effects of the fixed dose combination enalapril 10 mg/nitrendipine 20 mg vs losartan 50 mg/hydrochlorothiazide 12.5 mg, assessed by 24-h ambulatory blood pressure monitoring, in essential hypertensive patients.
    de la Sierra A, Gil-Extremera B, Calvo C, Campo C, García-Puig J, Márquez E, Oliván J, Roca Cusachs A, Sanz de Castro S, Pontes C, Delgadillo J.
    J Hum Hypertens; 2004 Mar 15; 18(3):215-22. PubMed ID: 14973517
    [Abstract] [Full Text] [Related]

  • 18. Discordance of anti-ischemic and hemodynamic effects of captopril in stable coronary artery disease.
    Winkelmann BR, Matheis G, Kleist P, Pötter S, Wohltmann D, Kaltenbach M.
    Coron Artery Dis; 1994 Oct 15; 5(10):829-44. PubMed ID: 7866603
    [Abstract] [Full Text] [Related]

  • 19. Evaluation of isradipine and captopril alone or in combination for the treatment of hypertension.
    Fitscha P, Meisner W, Hitzenberger G.
    J Cardiovasc Pharmacol; 1991 Oct 15; 18 Suppl 3():S12-4. PubMed ID: 1720478
    [Abstract] [Full Text] [Related]

  • 20. Effects of neutral endopeptidase inhibition and combined angiotensin converting enzyme and neutral endopeptidase inhibition on angiotensin and bradykinin peptides in rats.
    Campbell DJ, Anastasopoulos F, Duncan AM, James GM, Kladis A, Briscoe TA.
    J Pharmacol Exp Ther; 1998 Nov 15; 287(2):567-77. PubMed ID: 9808682
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 18.